Non-Anticoagulant Rodenticides Market worth $1.43 billion by 2030
According to a research report "Non-Anticoagulant Rodenticides Market by Type (Bromethalin, Cholecalciferol, Strychnine, and Zinc Phosphide), Mode of Application (Pellets, Spray, and Powder), End Use (Agriculture, Warehouses, Urban Centers), Rodent Type, and Region - Global Forecast to 2030 " published by MarketsandMarkets, The non-anticoagulant rodenticides market is projected to grow from USD 1.11 billion in 2025 and to reach USD 1.43 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period. The Non-Anticoagulant Rodenticide market is experiencing rising demand driven by rodent resistance to anticoagulants and stricter regulatory restrictions on traditional rodenticides. Growth in urbanization, food-processing, and agriculture is increasing the need for fast-acting, effective rodent control solutions. Products such as zinc phosphide, bromethalin, and cholecalciferol are preferred for their rapid action and lower risk of secondary poisoning. Additionally, food safety and environmental regulations are accelerating the adoption of low-residue, eco-friendly formulations. Market expansion is further supported by technological innovations such as microencapsulation, high-palatability baits, and sensor-integrated smart baiting systems, which enhance effectiveness while minimizing non-target exposure. These factors collectively drive growth across urban, industrial, and agricultural sectors globally.
Browse 150 market data Tables and 75 Figures spread through 210 Pages and in-depth TOC on "Non-Anticoagulant Rodenticides Market by Type (Bromethalin, Cholecalciferol, Strychnine, and Zinc Phosphide), Mode of Application (Pellets, Spray, and Powder), End Use (Agriculture, Warehouses, Urban Centers), Rodent Type, and Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/non-anticoagulant-rodenticides-market-13299457.html
The Cholecalciferol segment holds a significant market share in the type segment.
Cholecalciferol commands a respectable lead in the non-anticoagulant rodenticides by type, firstly due to its favorable efficacy profile, and secondly, regulatory acceptance is on the rise. With its mode of action based on vitamin D3, cholecalciferol provides efficient rodent control while minimizing the risks of secondary poisoning compared to many traditional anticoagulant products. This mode of action can aid in resistance management programs, particularly in regions where anticoagulant resistance is increasing. Furthermore, cholecalciferol rodenticides are widely used in urban, commercial, and agricultural settings because they mesh well with integrated pest management practices and comply with more stringent food-safety and public-health legislation, further consolidating their strong market position. Key players in the non-anticoagulant rodenticide market include Sumitomo Chemical (Japan), UPL Ltd./Arysta LifeScience (India), Bell Laboratories, Inc. (US), PCT Rural (Australia), and other players in the North American rodenticides market.
The spray segment holds a significant market share in the mode of application segment in the Non-Anticoagulant Rodenticides market during the forecasted period.
Spray holds a significant market share in the mode of application segment of the Non-Anticoagulant rodenticide market due to its ease of application, rapid surface coverage, and effectiveness in controlling rodent infestations in both agricultural and non-crop areas. Spraying ensures that active ingredients are uniformly distributed over vast areas: field crops, perimeter treatments, and high-risk infestation sites. It offers compatibility with fast-acting actives, such as zinc phosphide and bromethalin, in application modes ranging from manual to mechanical, which is a key factor in acceptance. The fact that spray applications can be integrated with other strategies within an integrated pest management program only strengthens their position in the market.
“Based on region, Asia Pacific holds a significant share in the Non-Anticoagulant Rodenticides market.
The Asia Pacific is a major contributor to the global non-anticoagulant rodenticides market, driven by high levels of rodent infestation in agricultural landscapes, rapid urbanization, and growth in food storage and logistics infrastructure. Large-scale cultivation of cereals, rice, and other staple crops generates a continuous demand for effective rodent control solutions, particularly in countries such as China, India, and Southeast Asian markets. Moreover, the increasing adoption of modern pest-control practices, rising awareness of crop-loss prevention, and supportive governmental initiatives for food security are accelerating the use of non-anticoagulant rodenticides. These two things, too-the presence of cost-sensitive markets and the extensive use of zinc phosphide-are really strengthening the market position of Asia Pacific.
The report profiles key players such as Bayer AG (Germany), Sumitomo Chemical (Japan), UPL Ltd (India), Bell Laboratories, Inc. (US), PCT Rural (Australia), Animal Control Technologies (Australia), Imtrade CropScience (Australia), Rentokil Initial plc (UK), AG Schilling & Co (Germany), 4Farmers Australia (Australia), Farmalynx Pty Ltd (Australia), Zagro (Malaysia), JT Eaton & Co., Inc. (USA), Neogen Technologies (USA), and Liphatech, Inc. (US). These companies are actively engaged in manufacturing and supplying zinc phosphide, bromethalin, cholecalciferol, and other non-anticoagulant rodenticides across agricultural, urban, and industrial sectors globally.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Non-Anticoagulant Rodenticides Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
